Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. - Wikidata - awgldk - TriplyDB

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

http://www.wikidata.org/entity/Q43511826

about

Diverse virulent pneumophages infect Streptococcus mitis CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials Antimicrobial bacteriophage-derived proteins and therapeutic applications Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection Role of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage Lysins Bacteriophages and phage-derived proteins--application approaches Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4 Cpl-7, a lysozyme encoded by a pneumococcal bacteriophage with a novel cell wall-binding motif Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectives Recombinant bacteriophage lysins as antibacterials Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.A genomic approach to understand interactions between Streptococcus pneumoniae and its bacteriophages LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation Wall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile.Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions.Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.The post-antibiotic era: promising developments in the therapy of infectious diseases.In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.Exploiting what phage have evolved to control gram-positive pathogens Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?1st German Phage Symposium-Conference Report.Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials

P2860

Q21090561-6299BDF4-8636-49FB-8B2B-D219668BDBDD Q24631662-BB398595-5CED-4887-B77B-F0EF4924B4B0 Q26744448-9CF47B5C-DBB2-4810-A565-CD4BB7740452 Q26781115-ABD28D6B-F85D-4286-BCC1-4FC39D3BF7E3 Q26998053-A07EC436-E8D7-4315-891C-99D58650BC85 Q27671535-0375CD38-BB82-4288-8533-70E92BC2962C Q28082731-CA2C3A66-5A4B-499A-A14B-6FA539520682 Q30010156-11DFA0C6-91C0-4433-AC21-39C228940A06 Q30392766-E3ABA86E-D26E-47CE-AD50-6E7CBC5AF4B2 Q33525230-43909D9F-2870-4EFC-BD26-AAF946463FE6 Q33749965-70ABAE4B-6F4D-48FB-A2ED-C8AB25979E80 Q34114172-1FC75D0B-3BAA-4EE1-B6BE-85B2137B9FDB Q34116324-A8ED2F32-6236-46F0-96A4-BB6A2F5EDE37 Q34303439-C2976288-4222-4197-AF04-0B9DDF8806EF Q34349552-78F59F8E-57F2-42BC-BE9F-E63C6E987F2E Q34558237-094B79E8-DA96-43EE-B220-66D800E8E9A0 Q35432724-FE8E413E-B8F9-4AB9-BBEA-96ADDFA2DB7B Q35845888-95D7CA02-399B-4D0F-BC19-AB9E7AC2EE4D Q37072798-895AD0D7-0D5C-4DCA-AAE3-6F1E9A301B1C Q37348810-B052BAFC-FC00-40A1-80EC-22FEE5D286CC Q37428714-1FC815E8-752F-45E6-88D3-8819E568F801 Q37696606-A42BAEC5-24A2-456D-9770-139B0BC25AC3 Q38106970-60605DA1-3D60-408A-964B-934B9AF2C063 Q38282910-6CFAABBD-ABF1-459F-BF39-716BC2D8EC18 Q38325227-1421F113-DACB-4DEF-989E-A317CBD7913B Q39029801-81DA117C-8FD2-4718-A931-B7BC280726BE Q40071759-BA89747C-3B57-4528-ACA6-B9AF0EC4264C Q40075857-723AB09E-40D8-4DCB-8DD7-965DC8AAC278 Q41657153-22ACE2C1-AE29-4972-BEF3-619E228FC828 Q41878765-52939BD0-0B1A-431A-9050-BCBB7B4EDA1E Q42072037-A916E6EE-5A2F-49D7-84F1-8A4653964AD1 Q42210341-56654DE2-97A3-454C-83AC-E12BC35262B2 Q42264677-F26719A8-049D-4367-8078-D9DD112BDA09 Q46251747-4C6F85F9-E7E1-45F9-A5CB-9EEBC4A2E3DB Q47588177-F4190C2A-C34B-4D6F-95B5-807787B09156 Q50016951-100D6F4F-26F3-4D3C-8A79-59B29DE885DC Q52622270-38B73E60-0EED-4A90-8840-0D6DDC1F560E Q52679093-5B1EFB30-F98E-46A2-B9AD-12F175B91682 Q54247935-80C8601B-8A84-44D8-86C8-469CE97C9A02 Q59128002-0122C822-72A4-43FC-8523-9EF98E7C2374

P2860

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

http://www.wikidata.org/entity/Q43511826

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@en

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@nl

type

label

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@en

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@nl

prefLabel

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@en

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

@nl

P1433

Q43511826-6566DB2C-12B6-46ED-9511-B514744D72BC

P1476

Q43511826-4FDDFFFD-01E1-4DA6-A613-1C16EF01B068

P2093

Q43511826-022153B1-AE69-43B0-9EFA-1F75A00A419C

Q43511826-133B2FD3-8F38-4A02-A6DB-9DDB246B7C97

Q43511826-5F993777-C8D1-46B7-A445-D5B3BE984D21

Q43511826-8FEBECAA-B4DD-4804-9ED4-EFCAA2442BA3

Q43511826-957852AC-B161-401F-B245-B3BEA54A2C49

Q43511826-96CAB51E-4E1D-4074-8482-C453A3AC9427

Q43511826-A86B07BF-D87F-44C7-BF2B-EDB5283AE406

Q43511826-ABD473AD-C2BB-4B36-9CE1-0CC9008A924B

Q43511826-D675208E-3111-4EDC-9E2D-084E4171BBD1

Q43511826-E26AFAC5-A520-441E-87C8-5807227EA2F1

P304

Q43511826-30C1C3EC-4F5C-4AC4-969F-035C7F587BCD

P31

Q43511826-C9421B54-B82A-417B-9491-0DDB1E4178B2

P356

Q43511826-8501BA7D-3B87-462F-8C3D-1E1800745F7C

P407

Q43511826-E7B2F62C-E74F-41A3-9A4A-9FCCCF467325

P433

Q43511826-EF148342-6DE1-4DCE-87F7-06E8FB7A05AB

P478

Q43511826-B6F24748-E098-4520-BF09-DB410A010F20

P50

Q43511826-29CF3F16-7443-416A-98ED-8447A33ACEFB

P577

Q43511826-EC564C75-78D1-4D9E-8DE0-0E7F709697A6

P698

Q43511826-260D9E6F-85DD-4C06-9376-C832D23CB798

P921

Q43511826-89BC467A-453B-4FA9-8814-0967514056DB

P356

CCM.0B013E31819586A6

P1433

Critical Care Medicine

P1476

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia

@en

P2093

Birgitt Gutbier

http://www.w3.org/2001/XMLSchema#string

Hartwig Schütte

http://www.w3.org/2001/XMLSchema#string

Holger Müller

http://www.w3.org/2001/XMLSchema#string

Jan M Doehn

http://www.w3.org/2001/XMLSchema#string

Janine Zahlten

http://www.w3.org/2001/XMLSchema#string

Jutta M Loeffler

http://www.w3.org/2001/XMLSchema#string

Maren Zemlin

http://www.w3.org/2001/XMLSchema#string

Martin Witzenrath

http://www.w3.org/2001/XMLSchema#string

Norbert Suttorp

http://www.w3.org/2001/XMLSchema#string

Simone Rosseau

http://www.w3.org/2001/XMLSchema#string

P304

642-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCM.0B013E31819586A6

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19114881

http://www.w3.org/2001/XMLSchema#string

P921